Acta Pharmaceutica, Vol. 71 No. 2, 2021.
Preliminary communication
https://doi.org/10.2478/acph-2021-0016
Identification of potential COVID-19 main protease inhibitors using structure-based pharmacophore approach, molecular docking and repurposing studies
SAFA DAOUD
; Department of Pharmaceutical Chemistry and Pharmacognosy, Faculty of Pharmacy, Applied Science Private University, Amman, Jordan
SHADA J. ALABED
; Department of Pharmaceutical Sciences, School of Pharmacy, The University of Jordan, Amman, Jordan
LINA A. DAHABIYEH
; Department of Pharmaceutical Sciences, School of Pharmacy, The University of Jordan, Amman, Jordan
Abstract
Keywords
COVID-19; main protease; pharmacophore; structure-based modeling; docking study; remdesivir; repurposing
Hrčak ID:
238733
URI
Publication date:
30.6.2021.
Visits: 1.324 *